CDP6038
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for CDP6038, covering 2011-09-27 to 2024-11-15. Get the full timeline:
Most recent: Clinical Trial Update: To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate [Phase 1, Phase 2]